Search Results 2051-2060 of 14756 for anti-TNF drugs

  1. Aminolevulinic Acid (Topical Route) Precautions - Mayo Clinic

    For Levulan® Kerastick® topical solution: Avoid exposure to light if you experience stinging or burning on the treated areas before blue light treatment. During ...

  2. Dinutuximab (Intravenous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Unituxin. Descriptions. Dinutuximab injection is used in ...

  3. Science Saturday: Advancing cell-based regenerative therapy for heart failure - Mayo Clinic News Network

    "The safety and efficacy of stem cell therapy have been documented in advanced clinical trials, but the method of cell manufacturing had remained cost- ...

  4. New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows

    ROCHESTER, Minn. — Mayo Clinic researchers have shown a link between which type of oral anticoagulant (blood-thinning medication) a patient takes to prevent ...

  5. A Study Comparing the Safety of Tofacitinib versus Tumor Necrosis Factor Inhibitor in Patients with Rheumatoid Arthritis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... By condition, treatment or drug name. Search tips. A Study Comparing the ...

  6. Nontuberculosis Mycobacterial Infections Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine whether 2-drug therapy is non-inferior to 3-drug therapy against pulmonary mycobacterium avium complex (MAC) disease, ...

  7. A Study to Evaluate the Effectiveness of Nicotinamide Riboside and Pterostilbene Treatment to Protect the Kidneys in Patients with Complex Aortic Aneurysm Repair and Aortic Arch Reconstruction - Mayo Clinic

    A Study to Evaluate the Effectiveness of Nicotinamide Riboside and Pterostilbene Treatment to Protect the Kidneys in Patients with Complex Aortic Aneurysm ...

  8. Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA - Mayo Clinic

    Clinical Trials · Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA · More about research at Mayo ...

  9. Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments - Mayo Clinic News Network

    Some of the medications being used to treat COVID-19 are known to cause drug-induced prolongation of the QTc of some people. The QTc is an indicator of the ...

  10. Oxaliplatin (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...